Chapter 9: Q. 32 (page 252)
How does the extracellular matrix control the growth of cells?
Short Answer
If receptors are not in touch with the cell, appropriate functioning will not occur, leading to cell death.
Chapter 9: Q. 32 (page 252)
How does the extracellular matrix control the growth of cells?
If receptors are not in touch with the cell, appropriate functioning will not occur, leading to cell death.
All the tools & learning materials you need for study success - in one app.
Get started for freeWhat is the difference between intracellular signaling and intercellular signaling?
Cells grown in the laboratory are mixed with a dye molecule that is unable to pass through the plasma membrane. If a ligand is added to the cells, observations show that the dye enters the cells. What type of receptor did the ligand bind to on the cell surface?
HER2 is a receptor tyrosine kinase. In 30 percent of human breast cancers, HER2 is permanently activated, resulting in unregulated cell division. Lapatinib, a drug used to treat breast cancer, inhibits HER2 receptor tyrosine kinase autophosphorylation (the process by which the receptor adds phosphates onto itself), thus reducing tumor growth by 50 percent. Besides autophosphorylation, which of the following steps would be inhibited by Lapatinib?
a. Signaling molecule binding, dimerization, and the downstream cellular response.
b. Dimerization, and the downstream cellular response.
c. The downstream cellular response.
d. Phosphatase activity, dimerization, and the downsteam cellular response.
Histamine binds to the H1 G-protein-linked receptor to initiate the itchiness and airway constriction associated with an allergic response. If a mutation in the associated G-protein’s alpha subunit prevented the hydrolysis of GTP how would the allergic response change? a. More severe allergic response compared to normal G-protein signaling. b. Less severe allergic response compared to normal G-protein signaling. c. No allergic response. d. No change compared to normal G-protein signaling.
In certain cancers, the GTPase activity of the RAS G-protein is inhibited. This means that the RAS protein can no longer hydrolyze GTP into GDP. What effect would this have on downstream cellular events?
What do you think about this solution?
We value your feedback to improve our textbook solutions.